POP-OUT | CLOSE

An Information Portal to 105097 Biological Macromolecular Structures

 
N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide
 
ASW is found in 1 entries
ASW
  •   Chemical Component Summary   Hide
    Name N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide
    Identifiers N-[4-(acridin-9-ylamino)-3-methoxy-phenyl]methanesulfonamide
    Synonyms Amsacrine
    Formula C21 H19 N3 O3 S
    Molecular Weight 393.46 g/mol
    Type non-polymer
    Isomeric SMILES
    InChI
    InChI key XCPGHVQEEXUHNC-UHFFFAOYSA-N
     
  •   Drug Info: DrugBank Hide
    DrugBank ID DB00276   (Stereoisomeric match)
    Name Amsacrine
    Groups approved
    Description Aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects. [PubChem]
    Synonyms
    • 4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide
    • 4'-(9-Acridinylamino)methanesulfon-m-anisidide
    • 4'-(9-Acridinylamino)methanesulfon-meta-anisidide
    • 4'-(9-Acridinylamino)methanesulphon-m-anisidide
    • Acridinyl anisidide
    • Amsacrine
    • m-AMSA
    • mAMSA
    [more]
    Brand names
    • Amekrin
    • AMSA P-D
    • Amsidine
    • Amsidyl
    Affected organism Humans and other mammals
    Indication For treatment of acute myeloid leukaemia.
    Pharmacology Amsacrine is an aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects.
    Mechanism of action Amsacrine binds to DNA through intercalation and external binding. It has a base specificity for A-T pairs. Rapidly dividing cells are two to four times more sensitive to amsacrine than are resting cells. Amsacrine appears to cleave DNA by inducing double stranded breaks. Amsacrine also targets and inhibits topoisomerase II. Cytotoxicity is greatest during the S phase of the cell cycle when topoisomerase levels are at a maximum.
    Route of administration Intravenous
    Categories
    • Antineoplastic Agents
    • Intercalating Agents
    ATC-Code L01XX01
    AHFS-Code 10:00.00
    CAS number 51264-14-3
    Targets
    Name Sequence search Pharmacological action Actions
    Potassium voltage-gated channel subfamily H member 2   Search  unknown inhibitor
    DNA topoisomerase 2-alpha   Search  yes inhibitor
    DNA topoisomerase 2-alpha   Search  yes inhibitor
     
Ligand Image